Photodynamic therapy (PDT) was a common therapy for exudative AMD until it was replaced largely by intravitreal application of vascular endothelial growth factor (VEGF) inhibitors such as ranibizumab [14]. This evidence concerns the gene VEGFA and age-related macular degeneration.